Who Owns Revolution Medicines Stock?
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 189.99 +0.99%
Ownership breakdown
- Held by institutions
- 101.25%
- Institutions (% of float)
- 103.16%
- Held by insiders
- 1.85%
- Institutional holders
- 950
- Institutions 98.1%
- Insiders 1.9%
- Public and other 0.0%
Who owns Revolution Medicines stock?
Institutional investors own about 101.3% of Revolution Medicines's shares, spread across 950 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.85% of RVMD.
The largest institutional holders are Blackrock Inc. (6.39%), Farallon Capital Management LLC (6.32%) and FMR, LLC (5.69%). Together, the top 10 institutions control 48.3% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their RVMD positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RVMD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 13.70M | 6.39% | +22.1% |
| Farallon Capital Management LLC | 13.55M | 6.32% | -0.4% |
| FMR, LLC | 12.20M | 5.69% | +44.1% |
| Baker Bros. Advisors, LP | 11.44M | 5.34% | +19.8% |
| Jupiter Topco LLC | 10.74M | 5.01% | +100.0% |
| Darwin Global Management, Ltd. | 10.63M | 4.96% | +380.8% |
| Vanguard Capital Management LLC | 9.09M | 4.24% | +8.7% |
| Vanguard Portfolio Management LLC | 8.29M | 3.87% | +10.6% |
| Nextech Invest, Ltd. | 7.60M | 3.55% | 0.0% |
| Paradigm Biocapital Advisors LP | 6.36M | 2.97% | -4.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RVMD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.41M | 2.99% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 4.63M | 2.16% |
| Growth Fund of America | 2.96M | 1.38% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 2.67M | 1.25% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.47M | 1.15% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.29M | 1.07% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.99M | 0.93% |
| iShares Trust-iShares Biotechnology ETF | 1.43M | 0.67% |
| JPMorgan Trust II-JPMorgan Large Cap Growth Fund | 1.17M | 0.54% |
| iShares Trust-iShares Russell Mid-Cap Growth ETF | 1.08M | 0.50% |
Frequently asked questions
Who is the largest shareholder of Revolution Medicines?
Blackrock Inc. is the largest institutional shareholder of RVMD, owning 6.39% of shares outstanding (13.70M shares) as of its latest 13F filing.
What percentage of Revolution Medicines is owned by institutions?
Institutions own about 101.3% of RVMD shares and 103.2% of the public float.
How much of Revolution Medicines do insiders own?
Insiders, such as officers and directors, own about 1.85% of RVMD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.